Carbon Neutrality

Taiho Pharmaceutical is continually implementing a variety of energy-saving measures, including upgrading to high-efficiency air conditioners and freezers, adopting LED lights, and switching to alternative fuels. We pursue energy-saving by addressing both infrastructure and workplace practices. We are also promoting further decarbonization by procuring CO₂-free electricity and green power certificates.

Taiho Pharmaceutical is implementing a variety of initiatives to reduce CO₂ emissions. These include introducing energy-saving equipment to replace air conditioners, freezers, and various other equipment, which are the main sources of our CO₂ emissions, and by implementing initiatives that lead to energy conservation in our business. To achieve the Otsuka group's environmental target of reducing CO₂ emissions by 50% by 2028 compared to 2017, we will continue to implement further measures to reduce greenhouse gas emissions in cooperation with other Otsuka group companies.

Taiho Pharmaceutical is working with logistics companies to implement a modal shift in transportation methods from road vehicles to ships and railways, which place less burden on the environment. Since fiscal 2010, the Okayama Site has been certified as an eco-shipping facility that contributes to environmental measures through a modal shift.

Since fiscal 2005, Taiho Pharmaceutical has been introducing more hybrid vehicles to its sales vehicle fleet. With the increase in hybrid-powered vehicles, the CO₂ emissions of the sales fleet have been reduced and fuel efficiency has been improved. Even in models and regions where hybrid vehicles cannot be selected, we are introducing fuel-efficient, low-emission vehicles. We will continue to actively promote the introduction of fuel-efficient, low-emission vehicles to our vehicle fleet. We are also working to reduce the use of vehicles by promoting on-line interviews, etc.

To help realize a carbon-neutral society, we need to reduce CO₂ emissions not only in-house, but also across the entire value chain. For this reason, in 2015, Taiho Pharmaceutical began calculating emissions for the entire value chain based on the Corporate Value Chain (Scope 3) Accounting and Reporting Standard. We are working to reduce emissions throughout the value chain by taking the most effective steps first, such as reducing containers and packaging and reducing business trips by using more online meetings.

The Corporate Value Chain (Scope 3) Accounting and Reporting Standard is a GHG emissions accounting standard addressing the entire supply chain of an organization and was issued by the World Resources Institute (WRI) in November 2011.

To improve the transparency and reliability of environmental information, the Otsuka group obtains third-party assurance of the figures for its Scope 1 and Scope 2 GHG emissions, energy consumption, crude oil conversion, and Scope 3, Category 1 emissions. Taiho Pharmaceutical is included in the scope of assurance, and the reliability of the data will be further enhanced.

In April 2022, the Otsuka group joined RE100, a global initiative supporting organizations committed to using 100% renewable energy in their business activities. The group is actively working to reduce CO₂ emissions based on its 2050 Environmental Vision, "Net-Zero," which aims to eliminate the total environmental impacts across its business activities in order to support the transition to a decarbonized society.